AI assistant
Sending…
PLUS THERAPEUTICS, INC. — Director's Dealing 2015
Aug 25, 2015
34301_dirs_2015-08-25_611d350a-81c9-4ccd-8426-0d73b64c0481.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CYTORI THERAPEUTICS, INC. (CYTX)
CIK: 0001095981
Period of Report: 2015-08-24
Reporting Person: HEDRICK MARC H (Director, President and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-08-21 | Common Stock | P | 5000 | $0.35 | Acquired | 33600 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 504611 | Direct |
| Common Stock | 7500 | Indirect |
Footnotes
F1: These securities are owned by M Hedrick & T Hedrick TTEE Dr. Marc Hamilton Hedrick & TRA U/A DTD 09/13/1999.
More from PLUS THERAPEUTICS, INC.
Capital/Financing Update
2026
Jun 5
Regulatory Filings
2026
Jun 5
Capital/Financing Update
2026
Jun 1
Declaration of Voting Results & Voting Rights Announcements
2026
May 15
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 15
Regulatory Filings
2026
Apr 21
Board/Management Information
2026
Apr 9
Regulatory Filings
2026
Apr 8
Board/Management Information
2026
Mar 26